Lichen International Limited
LICN
$4.41
$0.11912.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.69M | 11.69M | 9.05M | 9.05M | 11.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.69M | 11.69M | 9.05M | 9.05M | 11.92M |
| Cost of Revenue | 4.34M | 4.34M | 3.57M | 3.57M | 4.67M |
| Gross Profit | 7.35M | 7.35M | 5.48M | 5.48M | 7.25M |
| SG&A Expenses | 10.48M | 10.48M | 4.63M | 4.63M | 2.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.82M | 14.82M | 8.20M | 8.20M | 7.21M |
| Operating Income | -3.13M | -3.13M | 851.00K | 851.00K | 4.70M |
| Income Before Tax | -2.97M | -2.97M | 883.50K | 883.50K | 4.72M |
| Income Tax Expenses | 474.00K | 474.00K | 500.00K | 500.00K | 1.23M |
| Earnings from Continuing Operations | -3.44M | -3.44M | 383.50K | 383.50K | 3.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.50K | -9.50K | -- | -- | -- |
| Net Income | -3.45M | -3.45M | 383.50K | 383.50K | 3.49M |
| EBIT | -3.13M | -3.13M | 851.00K | 851.00K | 4.70M |
| EBITDA | -2.92M | -2.92M | 1.05M | 1.05M | 4.82M |
| EPS Basic | -17.00 | -17.00 | 2.58 | 2.58 | 26.34 |
| Normalized Basic EPS | -9.18 | -9.18 | 3.71 | 3.71 | 22.25 |
| EPS Diluted | -17.00 | -17.00 | 2.58 | 2.58 | 26.34 |
| Normalized Diluted EPS | -9.18 | -9.18 | 3.71 | 3.71 | 22.25 |
| Average Basic Shares Outstanding | 203.10K | 203.10K | 148.70K | 148.70K | 132.50K |
| Average Diluted Shares Outstanding | 203.10K | 203.10K | 148.70K | 148.70K | 132.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |